30-day mortality | 90-day mortality | |||||
---|---|---|---|---|---|---|
OR | (95% CI) | p value | OR | (95% CI) | p value | |
Age | ||||||
< 65 | 1.0 | Ref | ||||
65–74 | 0.4 | (0.1–1.9) | 0.29 | 0.7 | (0.2–2.2) | 0.53 |
75–84 | 1.6 | (0.5–4.7) | 0.40 | 1.9 | (0.7–4.8) | 0.21 |
> 85 | 1.9 | (0.6–6.0) | 0.26 | 4.2 | (1.6–11.5) | < 0.05 |
ASA score | ||||||
1–2 | 1.0 | Ref | ||||
3 | 3.9 | (1.4–10.9) | < 0.05 | 4.0 | (1.7–9.1) | < 0.05 |
4 | 18.4 | (5.7–58.7) | < 0.05 | 18.8 | (7.0–53.5) | < 0.05 |
M-stage | ||||||
0 | Ref | |||||
1 | 2.9 | (1.4–5.8) | < 0.05 | |||
Indication for surgery | ||||||
Obstruction | 1.0 | |||||
Bleeding | 0.8 | (0.2–4.0) | 0.80 | 1.8 | (0.5–5.8) | 0.35 |
Perforation | 1.2 | (0.4–3.0) | 0.77 | 1.7 | (0.7–3.6) | 0.16 |
Other | 1.1 | (0.3–4.5) | 0.86 | 2.1 | (0.6–5.9) | 0.22 |
Surgical specialization | ||||||
CRT | 1.0 | Ref | ||||
EST | 1.4 | (0.6–3.1) | 0.41 | 1.0 | (0.5–2.0) | 0.96 |
GST | 1.1 | (0.4–2.9) | 0.89 | 0.8 | (0.3–1.8) | 0.60 |